Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of chemoradiotherapy for oligometastatic stage IV non-small cell lung cancer
ChiCTR-TRC-14004170Phase 4Recruiting
- Sponsor
- Sichuan Cancer Hospital
- Start
- Jan 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cisplatin, docetaxel and pemetrexed in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Sichuan Cancer Hospital. Primary endpoints: Tumor size, Short-term efficacy and 1 more. Started Jan 2014; status: recruiting.
02
Drugs
cisplatindocetaxelpemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-14004170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004170.